Neurodegenerative disease reagents

Biomol International supplies a comprehensive range of reagents that can be used in various aspects of neurodegenerative research. Areas of application include: Alzheimer’s (tau proteins and antibodies, BACE reagents, DSK3 and CDK5 reagents and neprilysin); Parkinson’s (synuclein antibodies and proteins, Parkin antibody, tyrosine hydroxylase antibodies and dopamine antagonists); Huntington’s (glutamate and NMDA reagents, HDAC inhibitors, HATs, IGF1 reagents and Akt reagents); and Multiple Sclerosis (myelin basic proteins, serotonin reuptake inhibitors, monoamine transport inhibitors and cannabinoids).

Other neurodegenerative disease targets include: Apoptosis (detection kits, caspase reagents and mitochondrial permeability reagents); calcium signalling (Ca²⁺ chelators, ryanodine receptor reagents and calpain antibodies); oxidative stress (antioxidants, peroxiredoxin antibodies, heme oxygenase reagents and glutathione reagents); and nitric oxide (NOS assays and antibodies, NO donors and inhibitors and NOS inhibitors).